Cas Technology News Today

Governments relenting to the shut down with a shortterm funding deal. Mitch mcconnell praised the decision yesterday. After three days of an unnecessary lapse in funding, a bipartisan majority has brought the Democratic Leaders extraordinary filibuster to an end and pass the bipartisan deal to reopen the federal government. As i said repeatedly over the past week, shutting down the government isnt irresponsible way to do business. Markets rally on deal. The dow, nasdaq, s p 500 all closing recor...

▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity ▶ Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 15, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that New Drug Part has secured a potent anti-cancer candidate, PHAGERIA®, with broad antimicrobial activity against ETBF (Enterotoxige...

/PRNewswire/ -- The "Microbial Products: Technologies, Applications and Global Markets" report has been added to ResearchAndMarkets.coms offering. The total...

Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Microbial Products: Technologies, Applications and Global Markets" report has been added to ...

Share this article Share this article ResearchAndMarkets.coms offering. Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare. The ability to tailor the diagnostics and therapeutics offered to the patients is the key to precision medicine. The combination of biotechnology development, digitization of healthcare, and public investment led to the evolution of the personalization of disease-based therapies. This evolution within prec...